Integrated gut virome and bacteriome dynamics in COVID-19 patients

• Published in: Gut microbes Vol. 13; no. 1; p. 1
• Main Authors: Cao, Jiabao, Wang, Cheng, Zhang, Yuqing, Lei, Guanglin, Xu, Kun, Zhao, Na, Lu, Jingjing, Meng, Fanping, Yu, Linxiang, Yan, Jin, Bai, Changqing, Zhang, Shaogeng, Zhang, Ning, Gong, Yuhuan, Bi, Yuhai, Shi, Yi, Chen, Zhu, Dai, Lianpan, Wang, Jun, Yang, Penghui
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 01.01.2021; Taylor & Francis Group
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents - therapeutic use; bacteriome; Case-Control Studies; China; COVID-19; COVID-19 - microbiology; COVID-19 - therapy; COVID-19 - virology; Disease Models, Animal; dysbiosis; Dysbiosis - diagnosis; Female; Gastrointestinal Microbiome; genetic mutation; Genome, Viral; Humans; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Middle Aged; Research Paper; Transcriptome; Virome; China; COVID-19; virome; bacteriome; genetic mutation; dysbiosis

SARS-CoV-2 is the cause of the current global pandemic of COVID-19; this virus infects multiple organs, such as the lungs and gastrointestinal tract. The microbiome in these organs, including the bacteriome and virome, responds to infection and might also influence disease progression and treatment...